Research Article

Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway

See allHide authors and affiliations

Science  31 Aug 2018:
Vol. 361, Issue 6405, eaao3048
DOI: 10.1126/science.aao3048

Log in to view full text

Log in through your institution

Log in through your institution

Subjects

Navigate This Article